Hiroshi Tamura

Dr. Hiroshi Tamura

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
HTHiroshi Tamura
Hiroshi Tamura
ATAkihisa Takasaki
Akihisa Takasaki
TTToshiaki Taketani
Toshiaki Taketani
MTManabu Tanabe
Manabu Tanabe
FKFumie Kizuka
Fumie Kizuka
NSNorihiro Sugino
Norihiro Sugino
Melatonin (N-acetyl-5-methoxytryptamine) is secreted during the dark hours at night by pineal gland, and it regulates a variety of important central and peripheral actions related to circadian rhythms and reproduction. It has been believed that melatonin regulates ovarian function by the regulation of gonadotropin release in the hypothalamus-pituitary gland axis via its specific receptors. In addition to the receptor mediated action, the discovery of melatonin as a direct free radical scavenger has greatly broadened the understanding of melatonin's mechanisms which benefit reproductive physiology. Higher concentrations of melatonin have been found in human preovulatory follicular fluid compared to serum, and there is growing evidence of the direct effects of melatonin on ovarian function especially oocyte maturation and embryo development. Many scientists have focused on the direct role of melatonin on oocyte maturation and embryo development as an anti-oxidant to reduce oxidative stress induced by reactive oxygen species, which are produced during ovulation process. The beneficial effects of melatonin administration on oocyte maturation and embryo development have been confirmed by in vitro and in vivo experiments in animals. This review also discusses the first application of melatonin to the clinical treatment of infertile women and confirms that melatonin administration reduces intrafollicular oxidative damage and increase fertilization rates. This review summarizes our recent works and new findings related to the reported beneficial effects of melatonin on reproductive physiology in its role as a reducer of oxidative stress, especially on oocyte maturation and embryo development.

Verified
Journal Article
Open access
PDF file
HTHiroshi Tamura
Hiroshi Tamura
MJMai Jozaki
Mai Jozaki
MTManabu Tanabe
Manabu Tanabe
YSYuichiro Shirafuta
Yuichiro Shirafuta
YMYumiko Mihara
Yumiko Mihara
NSNorihiro Sugino
Norihiro Sugino
Melatonin is probably produced in all cells but is only secreted by the pineal gland. The pineal secretion of melatonin is determined by the light–dark cycle, and it is only released at night. Melatonin regulates biological rhythms via its receptors located in the suprachiasmatic nuclei of the hypothalamus. Melatonin also has strong antioxidant activities to scavenge free radicals such as reactive oxygen species (ROS). The direct free radical scavenging actions are receptor independent. ROS play an important role in reproductive function including in the ovulatory process. However, excessive ROS can also have an adverse effect on oocytes because of oxidative stress, thereby causing infertility. It is becoming clear that melatonin is located in the ovarian follicular fluid and in the oocytes themselves, which protects these cells from oxidative damage as well as having other beneficial actions in oocyte maturation, fertilization, and embryo development. Trials on humans have investigated the improvement of outcomes of assisted reproductive technology (ART), such as in vitro fertilization and embryo transfer (IVF-ET), by way of administering melatonin to patients suffering from infertility. In addition, clinical research has examined melatonin as an anti-aging molecule via its antioxidative actions, and its relationship with the aging diseases, e.g., Alzheimer’s and Parkinson’s disease, is also underway. Melatonin may also reduce ovarian aging, which is a major issue in assisted reproductive technology. This review explains the relationship between melatonin and human reproductive function, as well as the clinical applications expected to improve the outcomes of assisted reproductive technology such as IVF, while also discussing possibilities for melatonin in preventing ovarian aging.

27 November 2016 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
HTHiroshi Tamura
Hiroshi Tamura
MKMai Kawamoto
Mai Kawamoto
SSShun Sato
Shun Sato
ITIsao Tamura
Isao Tamura
RMRyo Maekawa
Ryo Maekawa
NSNorihiro Sugino
Norihiro Sugino

1 January 2013 in Endocrine Journal
Verified
Journal Article
Closed access
HTHiroshi Tamura
Hiroshi Tamura
ATAkihisa Takasaki
Akihisa Takasaki
TTToshiaki Taketani
Toshiaki Taketani
MTManabu Tanabe
Manabu Tanabe
FKFumie Kizuka
Fumie Kizuka
NSNorihiro Sugino
Norihiro Sugino
This review summarizes new findings related to beneficial effects of melatonin (N-acetyl-5-methoxytryptamine) on reproductive physiology. Recently many researchers have begun to study the local role of melatonin as an antioxidant. We focused on intra-follicular role of melatonin in the ovary. Melatonin, secreted by the pineal gland, is taken up into the follicular fluid from the blood. Reactive oxygen species (ROS) are produced within the follicles, during the ovulatory process. Melatonin reduces oxidative stress as an antioxidant, and contribute to oocyte maturation, embryo development and luteinization of granulosa cells. Our clinical study demonstrated that melatonin treatment for infertile women increases intra-follicular melatonin concentrations, reduces intra-follicular oxidative damage, and elevates fertilization and pregnancy rates. Melatonin treatment also improves progesterone production by corpus luteum in infertile women with luteal phase defect. Melatonin treatment could become a new cure for improving oocyte quality and luteal function in infertile women.

7 October 2013 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
HTHiroshi Tamura
Hiroshi Tamura
ATAkihisa Takasaki
Akihisa Takasaki
TTToshiaki Taketani
Toshiaki Taketani
MTManabu Tanabe
Manabu Tanabe
LLLifa Lee
Lifa Lee
NSNorihiro Sugino
Norihiro Sugino

21 August 2017 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
PDF file
HTHiroshi Tamura
Hiroshi Tamura
HKHiroshi Kishi
Hiroshi Kishi
MKMari Kitade
Mari Kitade
MAMikiko Asai‐Sato
Mikiko Asai‐Sato
ATAtsushi Tanaka
Atsushi Tanaka
NSNorihiro Sugino
Norihiro Sugino
Purpose: To investigate the impact of adenomyosis on the complications and outcomes of pregnancy in Japan.Methods: We carried out a multicenter retrospective questionnaire survey. A questionnaire regarding pregnancy complications and the outcomes of pregnancy was sent to 725 facilities.Results: Data were obtained on the cases of 272 pregnant women with adenomyosis from 65 facilities. The complications of pregnancy included miscarriage before 12 weeks of pregnancy (14.8%), miscarriage after 12 weeks of pregnancy (9.9%), preterm delivery (24.4%), fetal growth restriction (11.8%), pregnancy‐induced hypertension (9.9%), intrauterine infection (7.3%), and cervical incompetency (5.3%). The rates of pregnancy complications in the three groups classified according to pretreatment for adenomyosis (no pretreatment, medication, surgery) did not differ to a statistically significant extent. The rates of miscarriage (>12 weeks) and cervical incompetency increased according to the size of the adenomyosis. The rates of pregnancy‐induced hypertension and uterine infection in patients with diffuse‐type adenomyosis were higher than that in patients with focal‐type adenomyosis.Conclusions: Our results show that the increased size and diffuse type of adenomyosis are associated with adverse pregnancy outcome. We should be aware of the higher incidence of pregnancy‐induced hypertension and uterine infection in patients with diffuse‐type adenomyosis.